Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which therapy wins for chronic neck pain? new study tests three options

NCT ID NCT07490366

Symptom relief Sponsor: Eren Başıbüyük Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three treatments—exercise, dry needling, and a newer injection called interfascial block—for people with long-lasting pain in the upper back muscle (trapezius). About 78 adults aged 18 to 55 with at least 3 months of pain will be assigned to one of the three groups. The goal is to see which treatment works best for reducing pain, improving movement, and boosting quality of life, both in the short and long term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 78 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Myofascial pain in the upper trapezius muscle that has lasted for at least 3 months * VAS score of 4 or higher for the current pain * Clinically diagnosed with myofascial pain in the trapezius muscle * Ages 18 to 55 * Patients who can follow verbal instructions and have no cognitive deficits Exclusion Criteria: * Having received interventional injections in the neck and shoulder area within the last 3 months * Having received physical therapy within the last 3 months * Having received regular nonsteroidal anti-inflammatory and myorelaxant treatment within the last month * History of surgery on the affected side (neck or shoulder) * Chronic inflammatory disease * Acute infection * History of malignancy * Coagulation disorders * Pregnancy * Liver and kidney pathologies * Drug allergy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myofascial pain of upper trapezius muscle are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity myofascial pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myofascial pain of upper trapezius muscle

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Haydarpaşa Training and Research Hospital

    RECRUITING

    Istanbul, Istanbul, 34668, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.